Therapeutic Vaccines for Tuberculosis: An Overview
Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world’s deadliest bacterial infection, resulting in more than 1.4 million deaths annually. The emergence of drug-resistance to first-line antibiotic therapy poses a threat to successful treatment, and novel therapeutic options are requir...
Main Authors: | Rania Bouzeyen, Babak Javid |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.878471/full |
Similar Items
-
mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01) -
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
by: Yu-Shiuan Wang, et al.
Published: (2023-10-01) -
An Overview of the Development of New Vaccines for Tuberculosis
by: E. Whitlow, et al.
Published: (2020-10-01) -
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01) -
COVID-19 Vaccines: An Overview of Different Platforms
by: Dmitry Kudlay, et al.
Published: (2022-02-01)